Skip to main content
. 2019 Sep 26;34(3):314–322. doi: 10.3803/EnM.2019.34.3.314

Table 2. The Top 20 Differentially Expressed Genes in Invasive PAs Compared with Noninvasive PAs (|FC|≥2, FDR <0.1).

Gene Gene description Log2FC FDR
Up-regulated genes
ZCCHC12 Zinc finger CCHC-type containing 12 2.81 0.047
NEFM Neurofilament, medium polypeptide 2.54 0.073
SCD Stearoyl-CoA desaturase 2.42 0.055
DCX Doublecortin 2.24 0.026
EPHA7 EPH receptor A7 2.17 0.026
SLC24A2 Solute carrier family 24 member 2 2.12 0.040
FRMPD1 FERM and PDZ domain containing 1 2.12 0.036
SLC8A2 Solute carrier family 8 member A2 2.01 0.059
RNF157 Ring finger protein 157 1.98 0.034
NRG1 Neuregulin 1 1.96 0.001
SLC32A1 Solute carrier family 32 member 1 1.88 0.056
CLDN9 Claudin-9 1.75 0.041
LRRN2 Leucine rich repeat neuronal 2 1.66 0.017
SCG2 Secretogranin II 1.65 0.041
NDRG4 N-myc downstream-regulated gene 4 protein 1.62 0.034
IL5RA Interleukin 5 receptor subunit alpha 1.62 0.014
FGF12 Fibroblast growth factor 12 1.62 0.031
NLRP1 NLR family pyrin domain containing 1 1.55 0.089
EEF1A2 Eukaryotic translation elongation factor 1 alpha 2 1.54 0.020
LANCL3 NDRG family member 4 LanC like 3 1.53 0.049
Down-regulated genes
MGP Matrix Gla protein −5.22 <0.001
DCN Decorin −5.13 <0.001
IGKC Immunoglobulin kappa constant −4.81 <0.001
C1S Complement C1s −4.58 <0.001
C1R Complement C1r −4.44 <0.001
TGM2 Transglutaminase 2 −4.41 <0.001
COL3A1 Collagen type III alpha 1 chain −4.17 0.012
IGFBP6 Insulin like growth factor binding protein 6 −3.97 <0.001
AGR2 Anterior gradient 2, protein disulfide isomerase family member −3.94 <0.001
SERPING1 Serpin family G member 1 −3.86 <0.001
BGN Biglycan −3.81 0.001
CYBRD1 Cytochrome b reductase 1 −3.80 <0.001
IGFBP4 Insulin like growth factor binding protein 4 −3.66 <0.001
AEBP1 AE binding protein 1 −3.66 <0.001
IFITM1 Interferon induced transmembrane protein 1 −3.65 0.001
FAT1 FAT atypical cadherin 1 −3.60 0.001
CFH Complement factor H −3.57 <0.001
COL6A2 Collagen type VI alpha 2 chain −3.53 0.004
ANXA1 Annexin A1 −3.47 0.001
TAGLN Transgelin −3.43 <0.001

PA, pituitary adenoma; FC, fold change; FDR, false discovery rate.